YALE ADVANCED FELLOWSHIP IN PULMONARY VASCULAR DISEASE

Yale School of Medicine
New Haven, CT

 

We are accepting applications for the Yale Fellowship in Pulmonary Vascular Disease for the year 2025! We will be accepting applications through July 2024.

Description

The Yale Advanced Fellowship in Pulmonary Vascular Disease is a one-year clinical fellowship. After completing the one-year clinical fellowship, fellows have an option of completing a second year with a focus on research. Potential research opportunities span basic science, translational research, and clinical research within cardiopulmonary physiology and pulmonary vascular disease.

Our clinical training program focuses on the evaluation and management of patients with diseases of the right heart system including pulmonary vascular disease, congenital heart disease, and end stage lung disease. Our program provides trainees with several unique clinical opportunities that are not readily available in most centers and provides a more in-depth and focused training experience than what is provided in general pulmonary and critical care and cardiology training programs.

Physicians who have completed an ACGME accredited fellowship in pulmonary and critical care medicine or cardiovascular medicine are invited to apply. We require the following documents:

  • Curriculum vitae (CV)
  • Personal statement
  • Three letters of recommendation

Further information about the Yale Advanced Fellowship in Pulmonary Vascular Disease can be found on our website: https://medicine.yale.edu/internal-medicine/pulmonary/education/fellowship-pulmonary-vascular-disease/ 

To Apply

Please feel free to share and distribute to trainees who might be interested. Interested applicants can submit their application and any requests for additional information to:

Sue Porto
Fellowship Coordinator
Email: [email protected]
Phone: 203-785-3207

Inderjit Singh MBChB, BMedSci, FRCP, FCCP
Assistant Professor of Medicine
Director, Yale Advanced Fellowship in Pulmonary Vascular Disease
Email: [email protected]

  

Posted on March 25, 2024